Advertisement
Advertisement
U.S. Markets open in 4 hrs 12 mins
Advertisement
Advertisement
Advertisement
Advertisement

Zynerba Pharmaceuticals, Inc. (ZYNE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
0.9300+0.0743 (+8.68%)
At close: 04:00PM EDT
0.8901 -0.04 (-4.29%)
After hours: 07:57PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/17/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 2.11
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 36.0700
52 Week Low 30.8360
50-Day Moving Average 31.6959
200-Day Moving Average 33.0767

Share Statistics

Avg Vol (3 month) 3334.38k
Avg Vol (10 day) 3358.96k
Shares Outstanding 541.22M
Implied Shares Outstanding 6N/A
Float 840.16M
% Held by Insiders 13.94%
% Held by Institutions 130.55%
Shares Short (Apr 28, 2022) 41.35M
Short Ratio (Apr 28, 2022) 44.85
Short % of Float (Apr 28, 2022) 43.23%
Short % of Shares Outstanding (Apr 28, 2022) 43.08%
Shares Short (prior month Mar 30, 2022) 41.36M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-29.61%
Return on Equity (ttm)-56.94%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -36.52M
Net Income Avi to Common (ttm)-37.31M
Diluted EPS (ttm)-1.0430
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)67.81M
Total Cash Per Share (mrq)1.63
Total Debt (mrq)562.76k
Total Debt/Equity (mrq)0.79
Current Ratio (mrq)8.10
Book Value Per Share (mrq)1.96

Cash Flow Statement

Operating Cash Flow (ttm)-33.46M
Levered Free Cash Flow (ttm)-19.28M
Advertisement
Advertisement